� Business Monitor International Ltd Page - dollar proportions which have been equalised to minimise currency fluctuations using a time series- weighted calculation. Europe s pharmaceutical market will post a five-year CAGR of -.- in USD terms and -.- CAGR in EUR terms. ...Nonetheless, despite the heavy focus on generic medicines in Emerging European markets, the increasing affordability of medicines will allow for greater access to medicines and in turn, boost sales growth in the region. Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (Europe ---------) ---- ---- ---- ---- ----f ----f ----f ----f ----f Pharmaceutical sales, USDbn ---.- ---.- ---.- --- ---.- --- ---.- ---.- ---.- Pharmaceutical sales, USDbn, y- o-y --.- -.- --.- --- --.- -.- -.- -.- -.- Pharmaceutical sales, USD per capita ---.- --- ---.- ---.- ---.- ---.- ---.- ---.- ---.- Pharmaceutical sales, of GDP -.- -.- -.- -.- -.- -.- -.- -.- -.- Pharmaceutical sales, of health expenditure --.- --.- --.- --.- --.- --.- --.- --.- --.- f = BMI forecast. These will in turn, pose revenue earning challenges for drugmakers. ...Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (Europe ---------) ---- ---- ---- ---- ----f ----f ----f ----f ----f Pharmaceutical sales, USDbn ---.- ---.- ---.- --- ---.- --- ---.- ---.- ---.- Pharmaceutical sales, USDbn, y- o-y --.- -.- --.- --- --.- -.- -.- -.- -.- Pharmaceutical sales, USD per capita ---.- --- ---.- ---.- ---.- ---.- ---.- ---.- ---.- Pharmaceutical sales, of GDP -.- -.- -.- -.- -.- -.- -.- -.- -.- Pharmaceutical sales, of health expenditure --.- --.- --.- --.- --.- --.- --.- --.- --.- f = BMI forecast.
...Europe s healthcare market will post a five-year CAGR of -.- in USD terms and -.- in EUR terms. ...In particular, the rising incidence of chronic conditions amongst a population with strong bias towards branded drugs will continue to boost healthcare spending. Nevertheless, cost containment remains high on the agenda of all governments and efficiency measures will weigh on market growth - particularly within Western Europe. As such, opportunities will exist primarily in Emerging Europe where the expansion of access to healthcare services will continue Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts (Europe ---------) ---- ---- ---- ---- ----f ----f ----f ----f ----f ...Nevertheless, cost containment remains high on the agenda of all governments and efficiency measures will weigh on market growth - particularly within Western Europe. As such, opportunities will exist primarily in Emerging Europe where the expansion of access to healthcare services will continue Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts (Europe ---------) ---- ---- ---- ---- ----f ----f ----f ----f ----f
...BMI View: As governments continue to focus on reducing debts, the pharmaceutical industry will remain a target for cost containment. While governments have implemented harsh measures such as price cuts on medicines in previous years, in the coming years, growth in the Europe s pharmaceutical market will be restricted as a result of government efforts to ensure cost effective pricing and rational prescribing of medicines, and a shift towards greater patient contribution towards healthcare costs. ...BMI View: As governments continue to focus on reducing debts, the pharmaceutical industry will remain a target for cost containment. While governments have implemented harsh measures such as price cuts on medicines in previous years, in the coming years, growth in the Europe s pharmaceutical market will be restricted as a result of government efforts to ensure cost effective pricing and rational prescribing of medicines, and a shift towards greater patient contribution towards healthcare costs. ...
